143 related articles for article (PubMed ID: 10408820)
1. Pharmacology of G-1-64, a new nondepolarizing neuromuscular blocking agent with rapid onset and short duration of action.
Gyermek L; Lee C; Nguyen N
Acta Anaesthesiol Scand; 1999 Jul; 43(6):651-7. PubMed ID: 10408820
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular pharmacology of TAAC3, a new nondepolarizing muscle relaxant with rapid onset and ultrashort duration of action.
Gyermek L; Lee C; Cho YM; Nguyen N; Tsai SK
Anesth Analg; 2002 Apr; 94(4):879-85, table of contents. PubMed ID: 11916790
[TBL] [Abstract][Full Text] [Related]
3. Quaternary derivatives of granatanol diesters: potent, ultrashort acting non-depolarizing neuromuscular relaxants.
Gyermek L; Lee C; Cho YM; Nguyen N
Life Sci; 2006 Jul; 79(6):559-69. PubMed ID: 16516930
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium.
Savarese JJ; Belmont MR; Hashim MA; Mook RA; Boros EE; Samano V; Patel SS; Feldman PL; Schultz JA; McNulty M; Spitzer T; Cohn DL; Morgan P; Wastila WB
Anesthesiology; 2004 Apr; 100(4):835-45. PubMed ID: 15087618
[TBL] [Abstract][Full Text] [Related]
5. A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects.
Vizi ES; Tuba Z; Mahó S; Foldes FF; Nagano O; Dóda M; Takagi S; Chaudhry IA; Saubermann AJ; Nagashima H
Acta Anaesthesiol Scand; 2003 Mar; 47(3):291-300. PubMed ID: 12648195
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ
Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
[TBL] [Abstract][Full Text] [Related]
7. Muscle relaxants: a clinical update.
Buzello W; Diefenbach C; Nigrovic V
Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
10. Newer neuromuscular blocking agents: how do they compare with established agents?
Sparr HJ; Beaufort TM; Fuchs-Buder T
Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
[TBL] [Abstract][Full Text] [Related]
11. An overview of the pharmacology of rocuronium bromide in experimental animals.
Marshall RJ; Muir AW; Sleigh T; Savage DS
Eur J Anaesthesiol Suppl; 1994; 9():9-15. PubMed ID: 7925216
[TBL] [Abstract][Full Text] [Related]
12. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
Mirakhur RK
Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
[TBL] [Abstract][Full Text] [Related]
13. Comparison of neuromuscular block of atracurium and rocuronium in adults.
Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
[TBL] [Abstract][Full Text] [Related]
15. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
Savarese JJ; Lien CA; Belmont MR; Wastila WB
Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination.
Naguib M
Anesthesiology; 1994 Aug; 81(2):388-95. PubMed ID: 8053589
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the neuromuscular blocking and autonomic effects of two new short-acting muscle relaxants with those of succinylcholine in the anesthetized cat and pig.
Muir AW; Houston J; Marshall RJ; Bowman WC; Marshall IG
Anesthesiology; 1989 Mar; 70(3):533-40. PubMed ID: 2564263
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo neuromuscular effects of atracurium and rocuronium in rats treated with carbamazepine for seven days.
de Barcelos CC; Braga Ade F; Braga FS; Potério GB; Fernandes SC; Franco YO; Simioni LR
Rev Bras Anestesiol; 2008; 58(2):137-51. PubMed ID: 19378532
[TBL] [Abstract][Full Text] [Related]
19. Rocuronium onset of action: a comparison with atracurium and vecuronium.
Bartkowski RR; Witkowski TA; Azad S; Lessin J; Marr A
Anesth Analg; 1993 Sep; 77(3):574-8. PubMed ID: 8103649
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations.
Muir AW; Sleigh T; Marshall RJ; Pow E; Anderson KA; Booij LH; Hill DR
Eur J Anaesthesiol; 1998 Jul; 15(4):467-79. PubMed ID: 9699106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
